Clinical Trials Directory

Trials / Unknown

UnknownNCT06115304

Postprandial Profiles of Metabolites and Appetite-regulating Hormones in Plasma and Cerebrospinal Fluid

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Mikkel Bring Christensen · Academic / Other
Sex
Male
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

Overweight and obesity are rising in prevalence and becoming a growing threat to public health. Obesity is associated with an increased all-cause mortality, impaired quality of life, and numerous of disorders. Therapeutic strategies against obesity - which include an abundance of dietary and physical training programmes and pharmaceutical drugs to increase energy expenditure or limit appetite or gastro-intestinal fat absorption - have shown limited success on long term weight loss. Thus, overweight and associated conditions is becoming the new normal and there is a need for better understanding gut-to-brain signalling, hormonal and metabolic disturbances in overweight individuals. The purpose of this health science research project is to describe the coinciding plasma and cerebrospinal fluid (CSF) profiles of selected biomarkers after co-ingestion of a meal and model pharmaceuticals in patients with overweight and/or type 2 diabetes compared to healthy control individuals.

Conditions

Interventions

TypeNameDescription
OTHERLarge liquid meal, spinal catheter and venous lineLarge liquid meal (e.g. Nutricia® Energy 500 ml (750 kcal) admixed paracetamol 1000 mg (for estimation of gastric emptying). Spinal catheter for 4 hours, with samples taken at one hour interval. 2 venous lines, one for saline and one for venous sampling every half hour

Timeline

Start date
2023-10-05
Primary completion
2024-10-05
Completion
2024-10-10
First posted
2023-11-03
Last updated
2023-11-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06115304. Inclusion in this directory is not an endorsement.